Direct-acting antiviral therapies for hepatitis C genotype 1 infection: a multiple treatment comparison meta-analysis

Background: New direct-acting antiviral agents for hepatitis C genotype 1 infection, boceprevir and telaprevir, offer enhanced sustained virologic response (SVR) among both treatment-naïve and treatment-experienced patients. Aim: To determine the relative efficacy of the new direct-acting antiviral...

Descripción completa

Detalles Bibliográficos
Autores principales: Cooper, C., Lester, R., Thorlund, K., Druyts, E., El Khoury, A.C., Yaya, S., Mills, E.J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2013
Materias:
Original Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3550598/
https://www.ncbi.nlm.nih.gov/pubmed/23159839
http://dx.doi.org/10.1093/qjmed/hcs214

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3550598/
https://www.ncbi.nlm.nih.gov/pubmed/23159839
http://dx.doi.org/10.1093/qjmed/hcs214

Ejemplares similares